newsfilter
← Latest News
GlobeNewswire·

Reneo Pharmaceuticals Announces Notice of Allowance for Patent Application on REN001

IRVINE, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases,